Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

37.84
+0.22000.58%
Post-market: 37.840.00000.00%16:01 EDT
Volume:502.06K
Turnover:18.99M
Market Cap:2.89B
PE:-12.58
High:38.55
Open:37.65
Low:37.45
Close:37.62
Loading ...
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 14, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Major Issues Report

8-K - Current report
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]